Platelet Factor 4 Interactions with Short Heparin Oligomers: Implications for Folding and Assembly.


Journal

Biophysical journal
ISSN: 1542-0086
Titre abrégé: Biophys J
Pays: United States
ID NLM: 0370626

Informations de publication

Date de publication:
06 10 2020
Historique:
received: 06 02 2020
revised: 11 04 2020
accepted: 13 04 2020
pubmed: 30 4 2020
medline: 15 5 2021
entrez: 30 4 2020
Statut: ppublish

Résumé

Association of platelet factor 4 (PF4) with heparin is a first step in formation of aggregates implicated in the development of heparin-induced thrombocytopenia (HIT), a potentially fatal immune disorder affecting 1-5% of patients receiving heparin. Despite being a critically important element in HIT etiology, relatively little is known about the specific molecular mechanism of PF4-heparin interactions. This work uses native mass spectrometry to investigate PF4 interactions with relatively short heparin chains (up to decasaccharides). The protein is shown to be remarkably unstable at physiological ionic strength in the absence of polyanions; only monomeric species are observed, and the extent of multiple charging of corresponding ions indicates a partial loss of conformational integrity. The tetramer signal remains at or below the detection threshold in the mass spectra until the solution's ionic strength is elevated well above the physiological level, highlighting the destabilizing role played by electrostatic interactions vis-à-vis quaternary structure of this high-pI protein. The tetramer assembly is dramatically facilitated by relatively short polyanions (synthetic heparin-mimetic pentasaccharide), with the majority of the protein molecules existing in the tetrameric state even at physiological ionic strength. Each tetramer accommodates up to six pentasaccharides, with at least three such ligands required to guarantee the higher-order structure integrity. Similar results are obtained for PF4 association with longer and structurally heterogeneous heparin oligomers (decamers). These longer polyanions can also induce PF4 dimer assembly when bound to the protein in relatively low numbers, lending support to a model of PF4/heparin interaction in which the latter wraps around the protein, making contacts with multiple subunits. Taken together, these results provide a more nuanced picture of PF4-glycosaminoglycan interactions leading to complex formation. This work also advocates for a greater utilization of native mass spectrometry in elucidating molecular mechanisms underlying HIT, as well as other physiological processes driven by electrostatic interactions.

Identifiants

pubmed: 32348723
pii: S0006-3495(20)30332-5
doi: 10.1016/j.bpj.2020.04.012
pmc: PMC7567982
pii:
doi:

Substances chimiques

Platelet Factor 4 37270-94-3
Heparin 9005-49-6

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1371-1379

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM112666
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Références

Platelets. 2018 May;29(3):249-256
pubmed: 29172900
Blood. 2008 Apr 1;111(7):3458-67
pubmed: 18094327
J Am Chem Soc. 2016 Oct 5;138(39):13059-13067
pubmed: 27611601
Clin Appl Thromb Hemost. 2017 Oct;23(7):725-734
pubmed: 28118750
Carbohydr Res. 2007 Feb 26;342(3-4):430-9
pubmed: 17229412
Mol Cell Proteomics. 2013 Apr;12(4):885-92
pubmed: 23325770
J Am Chem Soc. 2003 Mar 5;125(9):2817-26
pubmed: 12603172
Curr Proteomics. 2011;8(4):325-336
pubmed: 25705143
Eur J Cell Biol. 2011 Jun-Jul;90(6-7):521-6
pubmed: 21295372
Thromb Res. 2010 Apr;125(4):292-6
pubmed: 20004006
Methods. 2018 Jul 15;144:3-13
pubmed: 29704661
J Biol Chem. 1989 Feb 5;264(4):2092-9
pubmed: 2914894
Blood. 2005 Jan 1;105(1):131-8
pubmed: 15304392
Anal Chem. 2007 Jun 1;79(11):4154-61
pubmed: 17477507
Biopolymers. 2010 Jul;93(7):619-39
pubmed: 20213767
Anal Chem. 2007 Aug 15;79(16):6055-63
pubmed: 17658885
Cytokine Growth Factor Rev. 2011 Feb;22(1):1-18
pubmed: 21111666
J Am Soc Mass Spectrom. 2008 Sep;19(9):1239-46
pubmed: 18602274
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2386-93
pubmed: 16873726
J Thromb Haemost. 2020 Feb;18(2):390-398
pubmed: 31573759
Thromb Haemost. 2016 Oct 28;116(5):783-791
pubmed: 27658429
J Biol Chem. 2005 Sep 16;280(37):32200-8
pubmed: 16033763
J Biol Chem. 1999 Sep 3;274(36):25317-29
pubmed: 10464257
Blood. 2007 Dec 15;110(13):4253-60
pubmed: 17848616
J Lab Clin Med. 1951 Jul;38(1):1-10
pubmed: 14850832
Anal Chem. 2016 Feb 2;88(3):1711-8
pubmed: 26707758
Analyst. 2020 Apr 14;145(8):3090-3099
pubmed: 32150181
Biochem J. 1995 Dec 1;312 ( Pt 2):357-65
pubmed: 8526843
Biochim Biophys Acta. 1975 Feb 27;379(2):370-84
pubmed: 1122293
J Am Soc Mass Spectrom. 2011 Oct;22(10):1679-89
pubmed: 21952881
Anal Chem. 2010 Sep 15;82(18):7523-6
pubmed: 20731408
Biochem J. 1980 Dec 1;191(3):769-76
pubmed: 7283972
Nat Commun. 2015 Sep 22;6:8277
pubmed: 26391892
Thromb J. 2013 Apr 05;11(1):7
pubmed: 23561460
Biochemistry. 1994 Jul 12;33(27):8361-6
pubmed: 8031770
Protein Sci. 2013 May;22(5):530-44
pubmed: 23436701
J Biol Chem. 2015 Apr 24;290(17):10729-40
pubmed: 25752613
Anal Chem. 2005 Aug 15;77(16):5370-9
pubmed: 16097782
Adv Colloid Interface Sci. 2010 Jul 12;158(1-2):119-29
pubmed: 20444439
J Biol Chem. 2017 Mar 10;292(10):4054-4063
pubmed: 28115521
Biochim Biophys Acta. 1972 Dec 29;286(2):312-29
pubmed: 4267228
Proteins. 1992 Oct;14(2):277-87
pubmed: 1409574
Methods. 2018 Jul 15;144:14-26
pubmed: 29702225
Biochem J. 1986 Mar 1;234(2):485-8
pubmed: 3718482
J Am Soc Mass Spectrom. 2017 Apr;28(4):758-767
pubmed: 28211013
Blood. 2017 May 25;129(21):2864-2872
pubmed: 28416511

Auteurs

Chendi Niu (C)

Chemistry Department, University of Massachusetts-Amherst, Amherst, Massachusetts.

Yang Yang (Y)

Chemistry Department, University of Massachusetts-Amherst, Amherst, Massachusetts.

Angela Huynh (A)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Ishac Nazy (I)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Igor A Kaltashov (IA)

Chemistry Department, University of Massachusetts-Amherst, Amherst, Massachusetts. Electronic address: kaltashov@chem.umass.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH